Article

Revolutionizing Cancer Therapy: A Comprehensive Review of Immune Checkpoint Inhibitors

2024-12-05

Abstract excerpt

Cancer treatment has undergone a transformative shift with the advent of immune checkpoint inhibitors (ICIs). By targeting critical immune checkpoints like programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), ICIs unleash robust anti-tumor immune responses while disrupting mechanisms that maintain immune homeostasis. This review explor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87bf4cff-59b8-5fff-a544-3bbe6d8a0c61
DOI: 10.20944/preprints202412.0505.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Revolutionizing Cancer Therapy: A Comprehensive Review of Immune Checkpoint InhibitorsDOI 10.20944/preprints202412.0505.v1Read

Tumor immune checkpoints and their associated inhibitorsSemantic proximity Read

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer TherapeuticsSemantic proximity Read

The evolving landscape of immune‐related adverse events that follow immune checkpoint immunotherapy in cancer patientsSemantic proximity Read

Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the uglySemantic proximity Read

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4Semantic proximity Read

Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint BlockadeSemantic proximity Read

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on BiomarkersSemantic proximity Read

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious DiseasesSemantic proximity Read

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on BiomarkersSemantic proximity Read

The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy.Semantic proximity Read

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlightsSemantic proximity Read

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathwaysSemantic proximity Read